Ligand Pharmaceuticals Inc (LGND)

Cash & Equivalents

$1.01B

Quarterly · Period ending: · USD

LGND logo

LGND Cash & Equivalents

Latest reported$1.01B
LGND Quarterly Cash & Equivalents ($2.10M → $1.01B)
High-resolution chart · PNG

LGND cash & equivalents history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Ligand Pharmaceuticals Inc Cash & Equivalents — Quarterly (USD)
Period endingCash & Equivalents (USD)
1,006,702,000
115,077,000
174,927,000
139,376,000
67,669,000
47,989,000
72,307,000
63,619,000
18,139,000
50,093,000
22,954,000
19,275,000
28,445,000
88,728,000
45,006,000
4,116,000
5,280,000
14,993,000
19,522,000
23,430,000
21,863,000
31,853,000
47,619,000
456,916,000
115,156,000
117,527,000
71,543,000
1,099,685,000
1,332,049,000
1,428,688,000
718,381,000
115,560,000
956,927,000
51,024,000
201,661,000
32,739,000
172,627,000
10,641,000
141,048,000
124,115,000
61,350,000
113,201,000
200,219,000
93,770,000
181,609,000
165,766,000
167,336,000
186,588,000
22,027,000
12,977,000
15,979,000
3,271,000
5,923,000
5,037,000
12,381,000
7,046,000
8,885,000
9,777,000
7,041,000
2,251,000
3,441,000
6,033,000
3,346,000
3,796,000
3,235,000
4,044,000
16,032,000
5,160,000
3,549,000
4,920,000
28,753,000
11,801,000
29,177,000
59,543,000
76,812,000
69,301,000
103,611,000
403,911,000
158,401,000
10,029,000
41,615,000
49,808,000
66,756,000
49,588,000
32,580,000
50,956,000
92,310,000
46,020,000
41,920,000
65,558,000
59,030,000
73,002,000
24,248,000
12,979,000
42,423,000
23,177,000
25,087,000
18,191,000
20,741,000
17,755,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.